Assessment of a High Throughput Next Generation Multiplex Respiratory Pathogen Panel

Assessment of a High Throughput Next Generation Multiplex Respiratory Pathogen Panel

21 Dec 2015

This poster evaluates the pilot assay performance of Luminex’s next generation NxTAG® Respiratory Pathogen Panel and demonstrates that it is capable of detecting multiple respiratory pathogens present in nasopharyngeal swab samples collected from symptomatic subjects. The Luminex NxTAG® Respiratory Pathogen Panel designed to simultaneously detect and discriminate nucleic acids from 19 viruses and 3 atypical and has a throughput capability of up to 96 reactions per run to simplify workflow. Respiratory tract infections are prevalent in adults and children, and are a particular danger to immunocompromised patients. There are many possible causative agents, including both viruses and bacteria, and a single patient may carry multiple infections. Therefore, rapid molecular diagnostic tests are vital mechanisms for detecting and differentiating many serious pathogens, which in turn reduces the use of broad spectrum antibiotics.

Links

Tags